This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College. Active years: 2021.
Company Filing History:
1 out of 1,265 
1 out of 3,071 
Years Active: 2021
Title: Michaela Bowden: Innovator in Prostate Cancer Diagnosis
Introduction
Michaela Bowden is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of prostate cancer. Her innovative work has the potential to improve patient outcomes and advance medical science.
Latest Patents
Michaela Bowden holds 1 patent for her invention titled "Compositions and methods for diagnosing prostate cancer using a gene expression signature." This invention relates to compositions and methods for the diagnosis, prognosis, and treatment of prostate cancer. It is based on the identification of a gene expression signature that predicts the likelihood of prostate cancer metastasizing. The patent provides a method for determining whether prostate cancer in a subject will metastasize, along with compositions comprising a prostate cancer-associated gene and kits that include a package with this gene.
Career Highlights
Throughout her career, Michaela has worked with esteemed institutions such as Dana-Farber Cancer Institute and Harvard College. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Michaela has collaborated with notable colleagues, including Massimo Loda and Lorelei Mucci. These partnerships have enriched her research and expanded the impact of her innovations in cancer diagnostics.
Conclusion
Michaela Bowden's contributions to prostate cancer diagnosis exemplify the importance of innovation in medical research. Her work not only enhances our understanding of cancer but also offers hope for improved diagnostic methods and treatments.